-
-
-
-
-
0
-
Classes
- All Drugs
- Allergy/Cold/ENT
- Anesthesia/Pain Management
- Asthma/Pulmonary
- Cardiovascular
- Dental/Oral Care
- Dermatologic
- Diagnostic
- Emergency
- Endocrine/Metabolism
- Gastrointestinal
- Hematology/Oncology
- Immunizations
- Immunology
- Infectious Disease
- Nephrology/Urology
- Neurologic
- Nutrition/Electrolytes
- Obstetrics/Gynecology
- Ophthalmic
- Psychiatric
- Rheumatologic
Endocrine/ Metabolism
Subclasses
- Androgens/ Androgen Agonists
- Antiandrogens, Non-oncologic
- Antiestrogens, Non-oncologic
- Appetite Stimulants
- Calcium Disorders
- Corticosteroids, Systemic
- Corticotropin-Releasing Factor Antagonists
- Cushing Syndrome
- Diabetes Insipidus
- Diabetes: Alpha-Glucosidase Inhibitors
- Diabetes: Amylin Mimetics
- Diabetes: Anti-CD3 Antibodies
- Diabetes: Biguanides
- Diabetes: Bile Acid Sequestrants
- Diabetes: Dopamine Agonists
- Diabetes: DPP-4 Inhibitors
- Diabetes: GIP/ GLP-1 Agonists
- Diabetes: GLP-1 Agonists
- Diabetes: Insulins
- Diabetes: Meglitinides
- Diabetes: Pancreatic Cell Therapy
- Diabetes: SGLT2 Inhibitors
- Diabetes: Sulfonylureas
- Diabetes: Thiazolidinediones (TZDs)
- Diagnostic Agents, Endocrine
- Estrogen Receptor Modulators, Selective (SERMs)
- Estrogen/ Androgen Precursors
- Estrogen/ Progestin Combos, Non-contraceptive
- Estrogens, Non-oncologic
- FGF23 Inhibitors
- GnRH Agonists
- Growth Hormone Antagonists
- Growth Hormones/ Agonists
- Hyperprolactinemia
- Hypoglycemia
- IGF-1R Antagonists
- Inherited Metabolic Disorders
- Metabolic Acidosis
- Mineralocorticoid Receptor Antagonists, Nonsteroidal
- Obesity/ Weight Management: GIP/ GLP-1 Agonists
- Obesity/ Weight Management: GLP-1 Agonists
- Obesity/ Weight Management: Lipase Inhibitors
- Obesity/ Weight Management: Melanocortin Receptor Agonists
- Obesity/ Weight Management: Non-Systemic Superabsorbent Hydrogels
- Obesity/ Weight Management: Opioid Antagonist/ Norepinephrine-Dopamine Reuptake Inhibitor (NDRI) Combos
- Obesity/ Weight Management: Sympathomimetics
- Osteoporosis: Bisphosphonates
- Osteoporosis: Calcitonin Analogs
- Osteoporosis: Calcium/ Vitamin D
- Osteoporosis: Estrogenic Agents
- Osteoporosis: Parathyroid Hormone (PTH) Analogs
- Osteoporosis: RANKL Inhibitors
- Osteoporosis: Sclerostin Inhibitors
- Parathyroid Disorders: Hyperparathyroidism
- Parathyroid Disorders: Hypoparathyroidism
- PI3K-alpha Inhibitors
- Porphyria
- Progestins, Non-contraceptive
- Skeletal Dysplasias
- Thyroid Disorders: Hyperthyroidism
- Thyroid Disorders: Hypothyroidism
- Thyroid Disorders: Thyroid Eye Disease
- Transgender Hormone Therapy, Feminizing
- Transgender Hormone Therapy, Masculinizing
Calcium Disorders |
|
|
|---|---|---|
Drug Names |
Generic Names |
|